Ensayos clínicos

8.676 ensayos encontrados

CompletadoClinicalTrials.gov

Prevalence of the Mutational Status of KRAS in mCRC in Argentine Patients

ObservacionalInicio: 1 de jun de 2009ID: NCT01082757

CompletadoFase 3ClinicalTrials.gov

An Open- Label Rollover Study for Subjects With Schizophrenia Completing ABILIFY® (Aripiprazole) Clinical Study 31-03-241

IntervencionalInicio: 1 de abr de 2006ID: NCT01001702

TerminadoFase 3ClinicalTrials.gov

An Open Label Study of the Safety, Tolerability and Effect on Hemoglobin Levels of Once-monthly Subcutaneous Mircera in Predialysis Patients With Chronic Renal Anemia Not Currently Treated With ESA.

IntervencionalInicio: 1 de abr de 2009ID: NCT00680563

CompletadoClinicalTrials.gov

Proportional Assist Ventilation for Minimizing the Duration of Mechanical Ventilation: The PROMIZING Study

IntervencionalInicio: 14 de sept de 2016ID: NCT02447692

CompletadoFase 4ClinicalTrials.gov

A Randomised, Double-Blind Placebo Controlled Trial Comparing the Effect of Intravenous Ferric Carboxymaltose on Hospitalisations and Mortality in Iron Deficient Patients Admitted for Acute Heart Failure (Affirm-AHF)

IntervencionalInicio: 3 de abr de 2017ID: NCT02937454

CompletadoFase 3ClinicalTrials.gov

A Multinational, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AVE5026 in the Prevention of Venous Thromboembolism (VTE) in Cancer Patients at High Risk for VTE and Who Are Undergoing Chemotherapy

IntervencionalInicio: 1 de jun de 2008ID: NCT00694382

CompletadoClinicalTrials.gov

Doubling Outcomes by Lung Cancer Early Diagnosis: An Observational, Study to Collect Real-world Evidence (RWE) on the Management of Pulmonary Nodules Across Latin-America

ObservacionalInicio: 30 de dic de 2021ID: NCT05091437

Activo, no reclutaFase 2ClinicalTrials.gov

Estudio de fase 1/fase 2, abierto, de escalada de dosis y expansión de dosis para evaluar la seguridad, tolerabilidad y eficacia de SAR444836, un vector viral adenoasociado para la transferencia génica de la fenilalanina hidroxilasa humana, en participantes adultos con fenilcetonuria

IntervencionalInicio: 7 de ago de 2023ID: NCT05972629

TerminadoClinicalTrials.gov

AO Multicenter Intervention Trial to Evaluate the Impact of a Bundle of Measures for the Prevention of Surgical Site Infection in Fracture Patients

IntervencionalInicio: 6 de dic de 2019ID: NCT03380273

CompletadoFase 3ClinicalTrials.gov

A Phase 3 Trial of ALIMTA (LY231514, Pemetrexed) Plus GEMZAR Versus GEMZAR in Patients With Unresectable or Metastatic Cancer of the Pancreas.

IntervencionalID: NCT00035035

CompletadoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Oral Lefamulin (BC 3781) Versus Oral Moxifloxacin in Adults With Community-Acquired Bacterial Pneumonia

IntervencionalInicio: 1 de ago de 2016ID: NCT02813694

CompletadoFase 2ClinicalTrials.gov

A Phase IIB, Multi-Center, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Safety and Clinical Efficacy of Two Different Doses of BMS-188667 Administered Intravenously to Subjects With Active Rheumatoid Arthritis While Receiving Methotrexate

IntervencionalInicio: 1 de oct de 2000ID: NCT00162266

TerminadoFase 2ClinicalTrials.gov

Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia

IntervencionalInicio: 6 de jul de 2020ID: NCT04477954

CompletadoFase 3ClinicalTrials.gov

Randomized, OpenLabel, Phase 3 Trial of Nivolumab Plus Ipilimumab or Nivolumab Plus Platinum Doublet Chemotherapy Versus Platinum Doublet Chemotherapy in Early Stage NSCLC

IntervencionalInicio: 4 de mar de 2017ID: NCT02998528

Activo, no reclutaFase 3ClinicalTrials.gov

Estudio de eficacia de fase 3, global, multicéntrico, doble ciego, aleatorizado, de zolbetuximab (IMAB362) más CAPOX frente a placebo más CAPOX como tratamiento de primera línea en participantes con adenocarcinoma gástrico o de la unión gastroesofágica (UGE) localmente avanzado irresecable o metastásico, positivo para claudina (CLDN) 18.2 y negativo para HER2

IntervencionalInicio: 28 de nov de 2018ID: NCT03653507

CompletadoFase 3ClinicalTrials.gov

A Phase III, Randomized, Multicenter, Double-Blind, Double Dummy, Parallel Group, Comparative Study to Determine the Efficacy, Safety, and Tolerability of Ceftazidime Avibactam (CAZ-AVI, Formerly CAZ104) Versus Doripenem Followed by Appropriate Oral Therapy in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis, With a Gram Negative Pathogen in Hospitalized Adults

IntervencionalInicio: 1 de oct de 2012ID: NCT01599806

CompletadoFase 3ClinicalTrials.gov

A 26-week Treatment, Randomized, Multicenter, Double-blind, Double-dummy, Parallel-group Study to Assess the Safety of Indacaterol (300 and 600 µg o.d.) in Patients With Moderate to Severe Persistent Asthma, Using Salmeterol (50 µg b.i.d.) as an Active Control

IntervencionalInicio: 1 de sept de 2007ID: NCT00529529

CompletadoClinicalTrials.gov

Intensity Lenses Post Operation Standard of Care Visits - Data Collection.

ObservacionalInicio: 13 de jul de 2023ID: NCT06220331

TerminadoFase 2ClinicalTrials.gov

A Multicenter, Double Blind, Randomized, Controlled Study of M7824 With Concurrent Chemoradiation Followed by M7824 Versus Concurrent Chemoradiation Plus Placebo Followed by Durvalumab in Participants With Unresectable Stage III Non-small Cell Lung Cancer

IntervencionalInicio: 16 de abr de 2019ID: NCT03840902

CompletadoFase 3ClinicalTrials.gov

Estudio de fase 3, multicéntrico, aleatorizado, doble ciego, controlado con placebo, para evaluar la seguridad y eficacia de LY2127399 en pacientes con artritis reumatoide (AR) con o sin terapia de base con fármacos antirreumáticos modificadores de la enfermedad (FAME) (FLEX O).

IntervencionalInicio: 1 de ene de 2011ID: NCT01202760